Transforming Growth Factor-β in Thoracic Aortic Aneurysms: Good, Bad, or Irrelevant?
- PMID: 28119286
- PMCID: PMC5523646
- DOI: 10.1161/JAHA.116.005221
Transforming Growth Factor-β in Thoracic Aortic Aneurysms: Good, Bad, or Irrelevant?
Keywords: Editorials; aneurysm; cytokine; transforming growth factor‐β pathway aneurysm; vascular biology.
Comment on
-
Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.J Am Heart Assoc. 2017 Jan 24;6(1):e004968. doi: 10.1161/JAHA.116.004968. J Am Heart Assoc. 2017. PMID: 28119285 Free PMC article.
References
-
- Dietz HC, Cutting CR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Setten G, Meyers DA, Francomano CA. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–339. - PubMed
-
- Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150–e157. - PubMed
-
- Wei H, Hu JH, Angelov SN, Fox K, Ysan J, Enstrom R, Smith A, Dichek DA. Aortopathy in a mouse model of Marfan syndrome is not mediated by altered transforming growth factor β signaling. J Am Heart Assoc. 2017;5:e004968 DOI: 10.1161/JAHA.116.004968. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
